AstraZeneca Pharma India Limited (ASTRAZEN.NS) NSE

8,661.50

-48.5(-0.56%)

Updated at June 03 11:21AM

Currency In INR

Valuation

Market Cap194.13B
Enterprise Value190.75B
P/E Ratio116.13
PEG Ratio1.87
Price/Sales Ratio9.57
Price/Book Ratio24.95
Enterprise/Revenue9.42
Enterprise/EBITDA76.45

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.08
Operating Margin0.1

Management Effectiveness

Return On Assets0.09
Return On Equity0.23

Income Statement

Revenue22.76B
Revenue/Share910.12
Gross Profit6.02B
EBITDA2.62B
Net Income1.88B
Diluted EPS75.01

Balance Sheet

Total Cash4.49B
Total Cash/Share179.43
Total Debt1.11B
Total Debt/Equity0.13
Current Ratio1.77
Book Value Per Share349.07

Price History

52-Week Change-6.71
52-Week High10,691
52-Week Low7,551.5
Moving Average 50 Days8,356.45
Moving Average 200 Days8,753.83

Statistics

Average Volume10,289
Shares Outstanding25M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate32
Trailing Annual Dividend Yield0.37
Payout Ratio0.43
Last Split Factor5:1
Last Split DateJune 15, 2006